Table 4.
Results of application to Collaborative Initial Glaucoma Treatment Study dataset.
Scenario 1 | Scenario 2 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Quantity | 95% CI | 95% CI | 95% CI | 95% CI | 95% CI | 95% CI | |||||||
Sex | Female | 0.96 | (0.76, >0.99) | 0.99 | (0.95, >0.99) | −3.6 | (−34.7, 31.2) | 0.93 | (0.71, >0.99) | 0.99 | (0.93, >0.99) | −4.9 | (−46.2, 34.5) |
Male | 0.97 | (0.79, >0.99) | 0.99 | (0.91, >0.99) | −3.2 | (−30.0, 21.7) | 0.86 | (0.64, 0.97) | 0.96 | (0.81, >0.99) | −2.4 | (−30.7, 31.2) | |
Age | <60 | 0.97 | (0.78, >0.99) | 0.99 | (0.90, >0.99) | −1.7 | (−32.2, 23.8) | 0.92 | (0.71, >0.99) | 0.98 | (0.83, >0.99) | −2.6 | (−27.4, 24.2) |
≥60 | 0.96 | (0.75, >0.99) | 0.99 | (0.96, >0.99) | −2.8 | (−24.3, 23.0) | 0.84 | (0.61, 0.97) | 0.98 | (0.87, >0.99) | −1.7 | (31.9, 33.6) |